Official Publications Incyte Corporation

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
51.68 ^USD	+0.98%		-1.28%	-17.69%

04-24	Oppenheimer Adjusts Incyte Price Target to $84 From $92, Maintains Outperform Rating	MT
04-23	Transcript : Escient Pharmaceuticals, Inc., Incyte Corporation - M&A Call

SEC Filing 8K	02-12	CO
Slide show results	02-12	CO
Annual results	02-12	CO
SEC Filing 10K	02-12	CO
SEC Filing 10Q-3	30/10/23	CO
SEC Filing 8K	30/10/23	CO
Slide show Q3	30/10/23	CO
3rd quarter results	30/10/23	CO
Slide show half-year results	31/07/23	CO
1st-half-year results	31/07/23	CO
SEC Filing 10Q-2	31/07/23	CO
SEC Filing 8K	31/07/23	CO
Shareholders meeting voting results	13/06/23	CO
SEC Filing 8K	03/05/23	CO
SEC Filing 10Q-1	01/05/23	CO
Slide show Q1	01/05/23	CO
1st quarter results	01/05/23	CO
SEC Filing 8K	01/05/23	CO
Proxy Statments	27/04/23	CO
Slide show results	06/02/23	CO
Annual results	06/02/23	CO
SEC Filing 8K	06/02/23	CO
SEC Filing 10K	06/02/23	CO
Slide show Q3	31/10/22	CO
3rd quarter results	31/10/22	CO